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Summary: The generation. of leukotrienes 84 (LT84) and C4 (LTC4) by leucocytes
stimulated with Ca ionophore A23187 was examined in 71 patients with asthma (42
with atopic and 29 with nonatopic asthma) and 23 healthy controls. Of these patients,
22 had SOIA (steroid-dependent intractable asthma). 1. The generation of LT84 and
LTC4 by leucocytes was significantly more enhanced in patients with atopic, non-SOIA
asthma than in healthy subjects, but not in patients with nonatopic asthma. The
generation of LT84 and LTC4 in atopic asthma was significantly more decreased in
patients with SOIA than in those with non-SOIA. 2. The LTC4 generation was
significantly larger in attack stage than in attack-free stage of patients with atopic
and nonatopic asthma when they had not SOIA. However, no significant difference was
found in LT84 generation between attack and nonattack stages in these patients. 3. In
patients with SOIA, no significant differences were observed in the generation of LT84
and LTC4 between attack and nonattack stages. The results suggest that IgE-mediated
allergy and asthma attacks enhance and glucocorticoids inhibit the generation of LT84
and LTC4 by leucocytes.
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Introduct ion
Leukotrienes are potent pro-inflammatory
mediators contributing to pathophysiological
changes of the airways in asthma. Cys-
teinyl leukotrienes (cysLTs) display bronch-
oconstrictory effects 1 ~ increase mucus for-
mation 2) and bronchial wall edema3). The
cysLTs are mainly generated by eosinophils in
the late asthmatic reaction 4). The amount of
cysLTs produced is related to the eosinophil
activation state5). Leukotriene B4 (LTB4)
stimulates neutrophil chemotaxis and activa-
tion of the cells, leading to the release of
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mediators, emzymes, and superoxides 6). LTB4
selectively increases the number and percent-
age of neutrophils in the human lung7). It has
been shown that neutrophil inflammation
enhances bronchial hyperresponsiveness8 • 9).
LTB4 is mainly generated by neutrophils.
Preincubation of human neutrophils with
granulocyte/macrophage-stimulating factor
CGM-CSF) results in a modest increase in
LTB4 production in response to the chem-
otactic peptidelO).
In the present study, generation of LTC4
and LTB4 by peripheral leucocytes stimulated
with Ca ionophore A 23187 was examined in
patients with asthma in relation to IgE-
mediated allergy and glucocorticoid therapy.
Subjects and Methods
The subjects of this study was 71 patients
(43 females and 28 males) with asthma and
23 healthy subjects 02 females and 11 males,
mean age 54.3 years). The mean age of pa·
tients with asthma was 61.5 years (range
27-74 years) and mean level of serum IgE was
461 IU/ml (range 2-5195 IU/ml). Asthma
was diagnosed according to the criteria of
the American Thoracic Society (ATS)Il).
Among all subjects with asthma, 42 were
atopic, as shown by a positive RAST score
for inhalant allergens, and 29 were nonatopic,
whose mean serum IgE level was under 250
IU/ml and RAST score for inhalant aller-
gens was all negative. Twelve of 42 patients
with atopic asthma and 10 of 29 with
nonatoppic asthma had steroid-dependent
intractable asthma (SDIA).
The generation of leukotrienes, LTC4 and
LTB4, by peripheral leukocytes was assessed
by a method previously reported l ". Buffy coat
was separated by adding a quarter volume of
6 % dextran and followed by being left 1
hour at room temperature. After the number
of the cells was adjusted to 5X 10 6 /ml in
Tris ACM, Ca ionophore A23187 O.u g} was
added to the cell suspension. The mixed
solution was incubated for 15 min at 37"C,
and centrifuged at 3000 rpm for 30 min after
the addition of 4 times volume of pre-chilled
ethanol (finally 80% ethanol). Supernatant
was taken into the syringe filter (Toyo Roshi
Co, Japan), and the filtrate was decom-
pressed and dryed up to solid. The solid was
dissolved with 250 .u 1 of 50% ethanol. The
HPLC analysis for LTB4 and LTC4 was
performed by a method described by Lam,
et aP3). The results were expressed as ng/
5 X106 cells.
IgE antibodies against inhalant allergens,
house dust mite, cockroach and Candida
albicans, were estimated by radioallergosor-
bent test (RAST), and serum level of total
IgE was measured by radioimmunosorbent
test (RIST).
Statistically significant differences of the
mean were estimated using the unpaired
Student't test. A p value of <0.05 was reg-
arded as significant.
Results
Table 1 shows the characteristics of pa-
tients with atopic and nonatopic asthma.
The number of patients with positive RAST
score for inhalant allergens was significantly
larger in patients with atopic asthma than in
those with nonatopic asthma. The mean of
serum IgE was significantly higher in atopic
asthma than in nonatopic. The generation of
LTB4 by leucocytes stimulated with Ca
ionophore A23187 was significantly higher in
patients with atopic, non-SDIA (87.1 ± 43.9
ng/5 X10 6 cells) (mean±SD) compared to
the generation in healthy subjects (43.1 ±
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Table 1. Characteristics of patients with
atopic and nonatopic asthma
Asthma Mean a~e
type SOIA (years RAST(+) S-lgE(IU/ml)
(+) 62.4 10112 525·b
Atopic (83.3") (80-1187)
(- ) 60.1 28/30 750 cd
(93.3") (40-S195)
( +) 57.9 0/10 107 ec
Nonatoplc ( 2-215)
(- ) 65.2 0/19 139 bd( 10-236)
SOIA: steroid-dependent Intractable asthma, RAST(+);
number of patients with positive RAST score for Inhalant
allergens. a; p<O.OOl, band d; p<O.Ol. c; p<O.OS.
Healthy Atopic Nonatopic
subjects Bronchial asthma
Fig. 1. Generation of leukotriene B 4 (LTB 4)
by leucocytes in healthy subjects and
atopic and nonatopic patients with
non-SDIA ( m1 ) and SDIA ( .. ) at
attck-free stage. a; p < 0.001, b;
p < 0.01.
......
ab
III 80
Gl
U 70
'b
)( 60
II)
" SOClC
'-'
c 40 0o 0
0 0o 0
';; 030 o 0nl 0o 0
... 0
Gl o 00
c 20 o 0Gl 0o 0
Cl 0o 0
10 0..,. o 00II) o 0
I- 0o 0
...J 0
24.2 ng/5 x 10 6 cells) (p<O.OOI). A signifi-
cant difference was found in LTB4 generation
between atopic subjects. with SDIA and non-
SDIA. However, there was no significant
difference in LTB4 generation between pa-
tients with nonatopic asthma and healthy
controls (Fig. }).
The generation of LTC4 by leucocytes was
significantly larger in patients with atopic,
non-SDIA (79.3± 27.0 ng/5 X 10 6 cells) than
in healthy subjects (5.1 ± 5.2 ng/ 5 x 10 6
cells) (p<O.OO}). The LTC4 generation in
patients with atopic, non-SDIA was signifi-
cantly higher in patients with atopic, SDIA
(p<O.OO}), and in those with nonatopic,
non-SDIA (p < O.OO}) and SDIA (p < O.OO})
(Fig. 2).
The generation of LTB4 and LTC4 by
leucocytes was generally low in patients with
SDIA, and there were no significant differ-
ences in the generation of LTB4 and LTC4 by
leucocytes of these patients between attack
and attack-free stages (Fig. 3,4). The genera-
tion of LTB4 and LTC4 by leucocytes of
patients with non-SDIA was generally higher
compared to the generation in those with
SDIA. The LTC4 generation was significantly
higher in attack stages than in attack-free
stages of both atopic (p<0.02) (Fig. 5) and
nonatopic asthma (p<O.OS) (Fig. 6). How-
ever, no significant difference was present in
the LTB4 generation between attack and
attack-free stages.
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4. Generation of leukotrienes B 4 (LTB 4 )
and C 4 (LTC 4) by leucocytes In
patients with nonatopic SDlA In
relation to asthmatic cycle.
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5. Generation of leukotrienes B 4 (LTB 4)
and C 4 (LTC 4) by leucocytes in
patients with atopic non-SDlA in
relation to asthmatic cycle. a; p <
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3. Generation of leukotrienes B 4 (LTB 4)
and C 4 (LTC 4) by leucocytes in
patients with atopic SDlA in relation
to asthmatic cycle.
Healthy Atopic Nonatopic
subjects Bronchial asthma
Fig. 2. Generation of leukotriene C 4 (LTC 4)
by leucocytes in healthy subjects and
atopic and nonat6pic patients with
non-SDlA ( 1m ) and SDlA ( II ) at
attck-free stage. a, b, c, and d ;
p<O.OOl
Fig.
LTB4
160
--!!! 140QI
U
'b 120
....
)( 100In
"Cl 80c
--.,.
u 60
'0
C 40III
.,.
al 20I-
-'
0
(+) (-)
Discussion
LTC4 production is almostly exclusively
due to eosinophils8. 9.16). Eosinophils appear to
be important in asthma pathophysiology.
Accumulation of the cells into the airways
often associated with increased production of
LTC 417). The amount of LTC 4 production by
eosinophils depends not only on the number
of the cells but also on the degree of
activation'8). When antigen was challenged
into the airways, the concentration of LTC 4
increased strongly correlated with the number
of eosinophils migrated into the airways,
suggesting that antigen causes recruitment
and activation of the cells'9l.
In the present study, the generation of
LTB 4 and LTC 4 by leucocytes stimulated
with Ca ionophore A 23187 was examined in
patients with asthma in relation to IgE-
mediated allergy and glucocorticoid therapy.
It has been shown that stimulation with
ionophore A23187 induced a significantly
higher leukotriene C 4 generation from gran-
ulocytes of asthmatic children than from
granulocytes of healthy controls 5l . They also
demonstrated that granulocytes from patients
with a history of severe asthma displayed a
higher LTC 4 formation than granulocytes
from patients with less severe disease.
Our results also showed that the LTB 4
and LTC 4 generation was significantly
larger in patients with atopic, non-SDIA than
in healthy controls. However. the generation
of LTB 4 and LTC 4 was not significantly
more increased in patients with nonatopic
asthma than in healthy subjects. In atopic
asthma, the LTB 4 and LTC 4 generation
were significantly more suppressed in patients
with SDIA than in those with non-SDIA. The
results suggest that the generation of LTB 4
and LTC 4 by leucocytes is influenced by
IgE-mediated allergy and glucocorticoid reg-
LTC4
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(+) (-)
Asthma attack
Fig. 6. Generation of leukotrienes B4 (LTB4)
and C 4 (LTC 4 ) by leucocytes in pa-
tients with nonatopic non-SDIA in
relation to asthmatic cycle. a; p <
0.05.
Asthma is characterized by inflammatory
changes of the airways. in which inflamma-
tory cells such as lymphocytes. neutrophils
and eosinophils. and a number of cytokines
including leukotrienes released from these
cells participate in the late asthmatic reac-
tion. Among inflammatory cells. activated T
lymphocytes and eosinophils play an impor-
tant role in induction and persistence of the
reaction") .
Leukotriene B4 and cysLTs. LTC 4 . LTD 4
and LTE 4. play an important role in
pathophysiology of the airways of bronchial
asthma. A number of factors can influence
LTB 4 production as well as cysLTs. LTB 4
has a chemotactic action for neutrophils as
well as interleukin 8 (IL 8 ), which causes
bronchial hyperresponsiveness and airway
neutrophil accumulationl51 •
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lmen. Furthermore, the generation of LTC4
by leucocytes was significantly higher In
attack stage than in attack-free stage In
patients with non-SDIA. The results are
consistent with the data showing enhanced
production of LTC 4 by activated eosinophils
during antigen challenge'9J • Regarding asthma
type, the generation of LTC 4 by leucocytes
was significantly larger in atopic asthma
compared to the generation in nonatopic
disease in both attack and attack-free stages.
An important role of interleukin 5 CIL- 5 )
in IgE-mediated allergic reactions has been
shown by several investigators20• 21). Parallel
patterns of increase of IL- 5 and eosinophils
imply the possibility of a bidirectional inter-
action between them22. 23). These results may
suggest a possibility that LTC 4 generation
is more closely related to IgE-mediated reac-
tion than to other reaction, and influenced by
glucocorticoid regimen.
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IgE一mediatedalergyandLTC4
Ⅰ型アレルギー反応および副腎皮質ホルモンは気
管支慌息における末梢血白血球のロイコトリエン
B4およびC4産生に影響をおよぽす
谷崎勝朗,光延文裕,御船尚志,保崎泰弘,
芦田耕三,柘野浩史,岡本 誠,原田誠之,
高田真吾,越智浩二l),小出典男1)
岡山大学医学部附属病院三朝分院
1)医学部臨床検査医学
気管支嶋息71例および健康人23名を対象に､
CaionophoreA23187刺激時の末梢血白血球の
ロイコトリエンB4 (LTB4)およびC4
(LTC4)の産生能について検討を加えた｡な
お､71例中ステロイ ド依存性重症難治性瑞息
(SDIA)は22例であった.1.アトピー性､
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非SDIA症例におけるLTB4､LTC4産生
は､健康人と比べ有意に高い値を示したが､非ア
トピー性噂息では健康人との間に有意の差は見ら
れなかった｡ また､ ア トピー性曝息では､
SDIA症例において非SDIA症例に比べ､
LTB4､LTC4産生が有意に抑制されていた｡
2.非SDIA症例では､アトピー 性､非アトピー
性を問わず､LTC4産生は､非発作時に比べ発
作時に有意に冗進した状態であった｡ しかし､
LTB4産生には､非発作時､発作時との間に有
意の差は見られなかった｡3.SDIA症例では､
LTB4､LTC4産生と発作との有意の関連は
見られなかった｡
以上の結果より､IgE にmediateされるアレ
ルギー反応や嶋息発作はLTB4､LTC4産生
に促進的に､また副腎皮質ホルモンは抑制的に作
用することが示唆された｡
